"They" always do this to momo stocks. People KNOW what you own and you won't fall for the games! Perfect buying opportunity for patient investors this a.m.
The run might be over in clean-up companies, but vaccines are in the news!!!
Continual slap on the wrists! I wonder if they frequented THIS board? Looks like the "tide" is turning in the market and small cap biotechs are returning to favor!!
Oh, and there was nearly 1.5M traded a/h last night, and another near 1M this a.m., ALL over $2.
Never underestimate the gamesmanship in biotech ... just buy the dips! Remember that nearly 50% of the shares of the company are held by insiders ... they're not in the float and trading, either.
Vaccines are where it's at right now. The clean-up companies made their run. Now, it's about prevention!!
Just place your order in real time ... you will be fine. Don't chase. The market always gives you an opportunity to get in!!
Complete lack of common sense on the part of EVERYONE! Good God! Now, the guy from Nigeria, vomiting in his seat and dies, does NOT have Ebola? So says the CDC who examined him before taking the body off the plane! Yeah, right!!! I'm guessing they are trying to control panic!
Osiris Therapeutics, Inc. (OSIR), the leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announced today that it has entered into an exclusive commercial and development partnership for its cartilage product, Cartiform, with Arthrex, Inc. Arthrex is a global medical device company and the leader in new product development and medical education in orthopaedics and sports medicine, operating in over 90 countries throughout the world.
"We are excited to enter this strategic partnership with Arthrex, the clear industry leader in sports medicine, as well as in foot and ankle devices and instrumentation, to address an unmet need in cartilage repair that demands an innovative cellular regenerative medical solution," said Dwayne Montgomery, Osiris’ General Manager of Orthopaedics and Sports Medicine. Cartiform, a viable chondral allograft, offers a unique solution to repair and restore damaged cartilage in the knee, foot, ankle, and other major joints. Cartiform has demonstrated promising clinical outcomes
NOBODY is cheering Ebola! But, if you are a realist, you go to where the money is being made!
nlnk has gone from $22 to over $32 ... in human testing, results by December. Vaccine of choice so far!
He was immediately replaced with an A-lister!!! But, thanks for playing ... that was so $13.00 ago!
IF that is correct, as of Sept. 30 (which was BEFORE the Ebola situation), good luck!! That light they're staring at IS a freight train!
Look at the % held by insiders and then the % held by institutions! Low float and lots of it tied up!
So glad I bought the "CFO resigns dip"! lol
They just recycled trial results that had already been announced awhile back, but rehashed now.